These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 12410564
41. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line. Park HJ, Kim BC, Kim SJ, Choi KS. Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621 [Abstract] [Full Text] [Related]
42. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV. Oncogene; 2004 Jul 22; 23(33):5594-606. PubMed ID: 15184882 [Abstract] [Full Text] [Related]
43. JNK and NFκB dependence of apoptosis induced by vinblastine in human acute promyelocytic leukaemia cells. Calviño E, Tejedor MC, Sancho P, Herráez A, Diez JC. Cell Biochem Funct; 2015 Jun 22; 33(4):211-9. PubMed ID: 25914345 [Abstract] [Full Text] [Related]
44. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Liedtke C, Plümpe J, Kubicka S, Bradham CA, Manns MP, Brenner DA, Trautwein C. Hepatology; 2002 Aug 22; 36(2):315-25. PubMed ID: 12143039 [Abstract] [Full Text] [Related]
45. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. J Immunol; 1999 Dec 15; 163(12):6800-9. PubMed ID: 10586080 [Abstract] [Full Text] [Related]
46. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action. Takahashi N, Watanabe Y, Maitani Y, Yamauchi T, Higashiyama K, Ohba T. Int J Cancer; 2008 Feb 01; 122(3):689-98. PubMed ID: 17955489 [Abstract] [Full Text] [Related]
48. Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-κB inhibitor, in human prostate cancer androgen-independent cell lines. Hayashi S, Koshiba K, Hatashita M, Sato T, Jujo Y, Suzuki R, Tanaka Y, Shioura H. Int J Mol Med; 2011 Dec 01; 28(6):1033-42. PubMed ID: 21805026 [Abstract] [Full Text] [Related]
49. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Shimada K, Nakamura M, Ishida E, Kishi M, Konishi N. Carcinogenesis; 2003 Jun 01; 24(6):1067-75. PubMed ID: 12807754 [Abstract] [Full Text] [Related]
50. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. Shimada K, Matsuyoshi S, Nakamura M, Ishida E, Kishi M, Konishi N. Carcinogenesis; 2004 Jul 01; 25(7):1089-97. PubMed ID: 15001534 [Abstract] [Full Text] [Related]
51. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma. Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Mitsiades C, MItsiades N, Gong B, Bonham L, de Vries P, Munshi N, Richardson PG, Singer JW, Anderson KC. Cancer Res; 2003 Dec 01; 63(23):8428-36. PubMed ID: 14679006 [Abstract] [Full Text] [Related]
52. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Engedal N, Korkmaz CG, Saatcioglu F. Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819 [Abstract] [Full Text] [Related]
53. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1. Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M. Mol Carcinog; 2006 Jan 07; 45(1):26-37. PubMed ID: 16267831 [Abstract] [Full Text] [Related]
54. The mechanism of geranylgeraniol-induced apoptosis involves activation, by a caspase-3-like protease, of a c-jun N-terminal kinase signaling cascade and differs from mechanisms of apoptosis induced by conventional chemotherapeutic drugs. Masuda Y, Nakaya M, Aiuchi T, Hashimoto S, Nakajo S, Nakaya K. Leuk Res; 2000 Nov 07; 24(11):937-50. PubMed ID: 11086177 [Abstract] [Full Text] [Related]
55. MAPK signaling is involved in camptothecin-induced cell death. Lee S, Lee HS, Baek M, Lee DY, Bang YJ, Cho HN, Lee YS, Ha JH, Kim HY, Jeoung DI. Mol Cells; 2002 Dec 31; 14(3):348-54. PubMed ID: 12521296 [Abstract] [Full Text] [Related]
56. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation. Song YS, Park HJ, Kim SY, Lee SH, Yoo HS, Lee HS, Lee MK, Oh KW, Kang SK, Lee SE, Hong JT. Neurosci Res; 2004 May 31; 49(1):69-80. PubMed ID: 15099705 [Abstract] [Full Text] [Related]
57. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Faderl S, Lotan R, Kantarjian HM, Harris D, Van Q, Estrov Z. Leuk Res; 2003 Mar 31; 27(3):259-66. PubMed ID: 12537979 [Abstract] [Full Text] [Related]
58. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells. Darwiche N, Hatoum A, Dbaibo G, Kadara H, Nasr R, Abou-Lteif G, Bazzi R, Hermine O, de Thé H, Bazarbachi A. Leukemia; 2004 Mar 31; 18(3):607-15. PubMed ID: 14712289 [Abstract] [Full Text] [Related]
59. c-Jun does not mediate hepatocyte apoptosis following NFkappaB inhibition and partial hepatectomy. Schrum LW, Black D, Iimuro Y, Rippe RA, Brenner DA, Behrns KE. J Surg Res; 2000 Feb 31; 88(2):142-9. PubMed ID: 10644480 [Abstract] [Full Text] [Related]
60. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. Sun SY, Yue P, Lotan R. Mol Pharmacol; 1999 Mar 31; 55(3):403-10. PubMed ID: 10051523 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]